Here’s a roundup of the latest news coverage from Drug Topics®.
Drug Topics Salary Survey 2021:
We need your opinions for the Drug Topics® 2021 Year in Review survey
Tell us about your experience with the evolving COVID-19 landscape, including regulation changes, growth in remote services, shifts in patient behavior, and emerging financial challenges. Finish the survey, and we’ll enter you into a drawing for 1 of 4 $100 Amazon gift cards.* Take the survey now (* see survey rules)
Prioritizing the Mental Health of Providers Across the Country
Susan Lorenz-Fisher, vice president of corporate responsibility & sustainability, AmerisourceBergen, and Erin Briggs, senior pharmacy advisor, Americares, discuss mental health awareness and resources for pharmacists to support their mental health.
https://www.drugtopics.com/view/prioritizing-the-mental-health-of-providers-across-the-country
Companion Diagnostic for Atezolizumab FDA-Approved for Lung Cancer Treatment
The FDA has approved the VENTANA PD-L1 assay to assist in identifying which adult patients with stage II to IIIA non–small cell lung cancer whose tumors have PD-L1 expression on 1% or more of tumor cells are eligible to receive adjuvant atezolizumab following surgery and platinum-based chemotherapy.
Pack4U Expert Interview Part 2: Medication Delivery 2.0
Shane Bishop, Pack4U's founder, is a pharmacist and entrepreneur specializing in innovative patient-care models and the use of technology to improve adherence, patient health outcomes and quality measures.
https://www.drugtopics.com/view/pack4u-medication-delivery-and-patient-monitoring-part-2?seriesVid=1
COVID-19 Vaccine FDA-Recommended for Children Ages 5-11
The US Food and Drug Administration (FDA) committee voted on whether the emergency use authorization should be extended to children aged 5 to 11 years.
https://www.drugtopics.com/view/covid-19-vaccine-recommended-by-fda-for-children-ages-5-11
Increase Medication Adherence through Patient Relationships, Part 1
Tony Makarich, PharmD and vice president of clinical services at Catalyst Health Rx, sat down with Drug Topics® to discuss the benefits for health care providers of a relationship and team-based pharmacy model.
FDA Approves Belumosudil (Rezurock) for the Treatment of Patients with Chronic Graft-Versus-Host Disease (cGVHD)
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.